DOI QR코드

DOI QR Code

Integrative Korean Medicine Treatment for Idiopathic Glossopharyngeal Neuralgia: A Case Report

  • Kim, So Jeong (Department of Acupuncture and Moxibustion Medicine, College of Korean Medicine, Daejeon University) ;
  • Choi, Hyeon Kyu (Department of Acupuncture and Moxibustion Medicine, College of Korean Medicine, Daejeon University) ;
  • Kim, Min Ju (Department of Acupuncture and Moxibustion Medicine, College of Korean Medicine, Daejeon University) ;
  • Cha, Hyun Ji (Department of Acupuncture and Moxibustion Medicine, College of Korean Medicine, Daejeon University) ;
  • Lee, Young Rok (Department of Acupuncture and Moxibustion Medicine, College of Korean Medicine, Daejeon University) ;
  • Jang, Hyun Jin (Department of Acupuncture and Moxibustion Medicine, College of Korean Medicine, Daejeon University) ;
  • Jeong, Jeong Kyo (Department of Acupuncture and Moxibustion Medicine, College of Korean Medicine, Daejeon University) ;
  • Jeon, Ju Hyun (Department of Acupuncture and Moxibustion Medicine, College of Korean Medicine, Daejeon University) ;
  • Kim, Young Il (Department of Acupuncture and Moxibustion Medicine, College of Korean Medicine, Daejeon University)
  • Received : 2022.04.21
  • Accepted : 2022.07.13
  • Published : 2022.08.31

Abstract

Glossopharyngeal neuralgia is a skin-sensitive condition/disease that causes severe pain in the facial area predominantly innervated by the glossopharyngeal nerve. A 51-year-old man diagnosed with glossopharyngeal neuralgia who was hospitalized with severe pain that limited his daily life activities. From November 18, 2021, to March 4, 2022, he received inpatient (10 days) and outpatient treatment (35 times) using acupuncture, pharmacopuncture, and herbal medicine. His symptoms were assessed using the Numerical Rating Scale, Neuropathic Pain Scale, and the Self-report Leeds Assessment of Neuropathic Symptom and Signs. The pain reduced after 4 days of initiating Korean medicine treatment and was completely resolved within 4 months of treatment (Numerical Rating Scale score 4 to 0; Neuropathic Pain Scale score 49 to 8; Self-report Leeds Assessment of Neuropathic Symptoms and Signs score 18 to 0). Korean medicine treatment could be an option for treating patients with neuropathy who rely on analgesics.

Keywords

References

  1. Minagar A, Sheremata WA. Glossopharyngeal neuralgia and MS. Neurology 2000;54:1368-1370. https://doi.org/10.1212/WNL.54.6.1368
  2. Shah RJ, Padalia D [Internet]. Glossopharyngeal Neuralgia. Treasure Island (FL): StatPearls Publishing. 2022 Jan [cited 2022 Feb 17]. Available from: http://www.statpearls.com.
  3. Gaul C, Hastreiter P, Duncker A, Naraghi R. Diagnosis and neurosurgical treatment of glossopharyngeal neuralgia: Clinical f indings and 3-D visualization of neurovascular compression in 19 consecutive patients. J Headache Pain 2011;12:527-534. https://doi.org/10.1007/s10194-011-0349-x
  4. Finnerup NB, Sindrup SH, Jensen TS. The evidence for pharmacological treatment of neuropathic pain. Pain 2010;150:573-581. https://doi.org/10.1016/j.pain.2010.06.019
  5. Paolo F, Antonio F, Marco S, Giovanni T, Angelo F, Fabio C et al. Microvascular decompression for glossopharyngeal neuralgia: A long-term retrospectic review of the Milan-Bologna experience in 31 consecutive cases. Acta Neurochir (Wien) 2009;151:1245-1250. https://doi.org/10.1007/s00701-009-0330-5
  6. Korean Acupuncture & Moxibustion Society Textbook Compilation Committee. Acupuncture Medicine, 4th ed. Seoul (Korea): Hanmi Medicine Publish Company; 2016. p. 302-304, 431-466, 887-889.
  7. Park CH, Cho MR, Yoon YC, Leu CR. Clinical study of oriental - Western collaborative medical treatment 1 case of patient with glossopharyngeal neuralgia. J Korean Acupunct Moxibustion Soc 2000;17:180-187. [in Korean].
  8. Lee CW, Kang JY, Lee SH, Kim CH. A case report of patient with idiopathic glossopharyngeal neuralgia. J Korean Med Ophthalmol Otolaryngol Dermatol 2015;28:102-111. https://doi.org/10.6114/jkood.2015.28.2.102
  9. Byun H, Kang MJ, Jung CY, Park IS, Jo HS, Kim GH, et al. Determination of safe needling depth via X-ray at TE17(Yifeng) and ST7(Xiaguan). J Korean Acupunct Moxibustion Soc 2007;24:69-73.
  10. Yoo CK, Kwon GR. The bibilographic studies on aconiti ciliare tuber and radix aconiti. J Pharmacopunct 2001;4:87-93.
  11. Sohn EH, Kim BJ. Clinical scale for neuropathic pain. J Korean Neurol Assoc 2021;39:24-36. https://doi.org/10.17340/jkna.2021.2.18
  12. Galer BS, Jensen MP. Development and preliminary validation of a pain measure specific to neuropathic pain: The Neuropathic Pain Scale. Neurology 1997;48:332-338. https://doi.org/10.1212/WNL.48.2.332
  13. Bennett MI, Smith BH, Torrance N, Potter J. The S-LANSS score for identifying pain of predominantly neuropathic origin: Validation for use in clinical and posral Research. J Pain 2005;6:149-158.
  14. Teixeira MJ, deSiqueira SR, BorSengShu E. Glossopharyngeal neuralgia: Neurosurgical treatment and differential diagnosis. Acta Neurochir (Wien) 2008;150:471-475. https://doi.org/10.1007/s00701-007-1493-6
  15. Du T, Ni B, Shu W, Hu Y, Zhu H, Li Y. Neurosurgical choice for glossopharyngeal neuralgia: A benefit-harm assessment of long-term quality of life. Neurosurgery 2020;88:131-139.
  16. Reddy GD, Viswanathan A. Trigeminal and glossopharyngeal neuralgia. Neurol Clin 2014;32:539-552. https://doi.org/10.1016/j.ncl.2013.11.008
  17. Zhang R, Lao L, Ren K, Berman BM. Mechanisms of acupuncture-electroacupuncture on persistent pain. Anesthesiology 2014;120:482-503. https://doi.org/10.1097/ALN.0000000000000101
  18. Cankal D, Akkol EK, Kilinc Y, Ilhan M, Capasso R. An effective phytoconstituent aconitine: A realistic approach for the treatment of trigeminal neuralgia. Mediators Inflamm 2021;2021:6676063.
  19. Shin HW, Kang JH, Lee H. Efficacy of Soyeon pharmacopuncture on postauricular pain accompanied with peripheral facial paralysis. J Korean Acupunct Moxibustion Soc 2009;26:41-49. [in Korean].
  20. Mi XJ, Xu XY, Choi HS, Kim H, Cho IH, Yi TH et al. The immune-enhancing properties of Hwanglyeonhaedok-Tang-Mediated biosynthesized gold nanoparticles in macrophages and splenocytes. Int J Nanomedicine 2022;17:477-494.